Sec. 103. Fentanyl detection
219 words·~1 min read·
/bill/117/hr/2366/ih/section-103·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary, acting through the Assistant Secretary and in coordination with the Director of the Centers for Disease Control and Prevention, shall establish a pilot program through which 5 entities, in 5 States representing diverse regions, use chemical screening devices to identify contaminants, including fentanyl and fentanyl-related substances, in illicit street drugs. Not later than the end of fiscal year 2025, the Secretary shall— complete an evaluation of the most effective ways of expanding the pilot program under this subsection to decrease rates of overdose; and submit a report to the appropriate congressional committees on the results of such evaluation.
In this subsection, the term chemical screening device means an infrared spectrophotometer, mass spectrometer, nuclear magnetic resonance spectrometer, Raman spectrophotometer, ion mobility spectrometer, or any other device or other technology that is able to determine the presence of, or identify, one or more contaminants in illegal street drugs. To carry out this subsection, there is authorized to be appropriated $5,000,000 for each of fiscal years 2022 through 2026. The Secretary shall conduct or support research for the development or improvement of portable and affordable technologies related to testing drugs for fentanyl and fentanyl-related substances, including chemical screening device methods.
To carry out this subsection, there is authorized to be appropriated $25,000,000 for each of fiscal years 2022 through 2026.